Plain-English translation of NCT06896162 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to help cancer doctors use genetic testing to choose the best treatment for you. Instead of relying only on standard care, the study adds a special coordinator and pharmacist expert to guide the genetic testing process and help explain what the results mean for your specific cancer.
Many cancer patients could benefit from genetic testing that reveals which targeted drugs work best for their tumor, but many doctors don't order these tests or know how to use the results. This trial is testing whether making the process easier and adding expert support will help more patients get this potentially life-saving personalized care.
You likely qualify if…
You likely don't qualify if…
You will work with a precision oncology navigator who will help arrange your genetic testing and make sure results are completed. A clinical pharmacist expert will review your test results and provide recommendations to your doctor about treatment options tailored to your tumor's genetics. The study team will track whether this support helps your doctor choose targeted therapy and how it affects your health outcomes.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States